期刊
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
卷 672, 期 -, 页码 -出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.abb.2019.108069
关键词
Prodrug; Bioactivation; Coenzyme A; Pantothenate; Pantothenamide
资金
- Canadian Institute of Health Research (CIHR)
- Fonds de recherche du Quebec (FRQ) Audace program
- FRQ-RQRM initiative
- Australia National Health and Medical Research Council (NHMRC)
- National Science and Engineering Research Council of Canada (NSERC)
- McGill Fessenden Professorship
- McGill Tomlinson Professorship
- Walter Sumner Foundation
- Dr. and Mrs. Milton Leong fellowship in science
Prodrugs account for more than 5% of pharmaceuticals approved worldwide. Over the past decades several prodrug design strategies have been firmly established; however, only a few functional groups remain amenable to this approach. The aim of this overview is to highlight the use of coenzyme A (CoA) biosynthetic enzymes as a recently explored bioactivation scheme and provide information about its scope of utility. This emerging tool is likely to have a strong impact on future medicinal and biological studies as it offers promiscuity, orthogonal selectivity, and the capability of assembling exceptionally large molecules.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据